Dexcom Announces Upcoming Conference Presentations
02 August 2019 - 10:30PM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that management will
present an update on Dexcom at the following upcoming investor
conferences:
- Quentin Blackford, Executive Vice President and Chief Financial
Officer, and Steven Pacelli, Executive Vice President, Strategy and
Corporate Development, will present at the 39th Annual Canaccord
Genuity Growth Conference in Boston, MA, on Wednesday, August 7th,
2019 at 2:00 PM (ET). The presentation, which will occur live at
the InterContinental Boston Hotel, will be concurrently
webcast.
- Quentin Blackford, Executive Vice President and Chief Financial
Officer, will present at the Morgan Stanley 17th Annual Global
Healthcare Conference in New York, NY, on Monday, September 9th,
2019 at 9:55 AM (ET). The presentation, which will occur live at
the Grand Hyatt New York, will be concurrently webcast.
The link to the webcast will be available on the Dexcom website
at www.dexcom.com by navigating to “About Us,” then “Investor
Relations,” and finally “Events and Presentations” and will be
archived there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is
developing and marketing continuous glucose monitoring systems for
use by people with diabetes and by healthcare providers.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190802005092/en/
DexCom, Inc. Steven R. Pacelli Executive Vice President,
Strategy and Corporate Development (858) 200-0200
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Apr 2024 to May 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From May 2023 to May 2024